Aktie A2P4JC PEIJIA MEDICAL LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Peijia Medical Limited

Aktien

A2P4JC

KYG6981F1090

9996

Verzögert Hong Kong S.E.
Andere Börsenplätze
 09:08:03 28.03.2024 		% 5 Tage % 1. Jan.
3,66 HKD -3,94 % Intraday Chart für Peijia Medical Limited -.--% -50,47 %
02.04. Peijia Medical Limited verzögert Veröffentlichung des Jahresergebnisses 2023 CI
01.04. Peijia Medical verringert Verlust für 2023 bei einem Umsatzsprung von 76% MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
JenaValve Technology, Inc. announced that it has received $100.4 million in funding from a group of investors
Peijia Medical Limited Delays in Publication of 2023 Annual Results
Peijia Medical Narrows 2023 Loss as Revenue Jumps 76%
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial
Peijia Medical's 2023 Profit to Jump Up to 79.4%
Peijia Medical Limited Announces Unaudited Revenue Results for the Year Ended December 31, 2023
Peijia Medical's Stock Jumps on Positive Updates For Two Devices
Peijia Medical releases 2023 interim results, sales revenue grows rapidly and gross profit margin increases significantly
Peijia Medical Announces 2023 Interim Results
Peijia Medical Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Peijia Medical Enrolls First Patient in TaurusTrio Transcatheter System; Shares Up 4%
Peijia Medical Limited Announces First Patient in Multi-Center Registration Clinical Trial of Taurustrio?? Transcatheter Aortic Valve Replacement System in China
Peijia Medical's H1 Revenue Rises By Up to 94%
Peijia Medical Limited Provides Unaudited Revenue Guidance for the Period from January 1, 2023 to June 30, 2023
China Approves Peijia Medical Unit's Micro Guidewire for Neuro-Intervention Operations
Peijia Medical Limited Receives Approval from the National Medical Products Administration of the PRC for the Registration Application of DCwireTM Micro Guidewire
Peijia Medical Completes Two Commercial Implants with Trilogy System in Hong Kong
Peijia Medical's 2022 Loss Narrows 29%
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P4JC Aktie
  4. Nachrichten Peijia Medical Limited
  5. Andere Sprachen